Report overview
Tumor genomics, also known as cancer genomics, is an emerging sub-discipline in genomics, mainly through the high-throughput sequencing technology to associate genes with cancer. Tumor is a disease caused by the accumulation of DNA mutations that leads to an uncontrolled proliferation of cells and the formation of new organisms. The main goal of tumor genomics is to provide new methods for tumor diagnosis, tumor clinical outcome prediction and tumor target treatment by identifying new oncogenes or tumor suppressor genes.
This report aims to provide a comprehensive presentation of the global market for Tumor Genomics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tumor Genomics. This report contains market size and forecasts of Tumor Genomics in global, including the following market information:
Global Tumor Genomics Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global top five companies in 2023 (%)
The global Tumor Genomics market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Assays and Kits Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Tumor Genomics include Abbott Laboratories, Agilent Technologies, Inc, Bio-Rad Laboratories, Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd, Fluidigm Corporation, General Electric Company, Illumina, Inc. and Merck KGaA, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
We surveyed the Tumor Genomics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Tumor Genomics Market, by Type, 2019-2024, 2025-2030 ($ millions)
Global Tumor Genomics Market Segment Percentages, by Type, 2023 (%)
Assays and Kits
Instrument
Global Tumor Genomics Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global Tumor Genomics Market Segment Percentages, by Application, 2023 (%)
Diagnostics and Monitoring
Drug Discovery and Development
Biomarker Discovery
Global Tumor Genomics Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global Tumor Genomics Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Tumor Genomics revenues in global market, 2019-2024 (estimated), ($ millions)
Key companies Tumor Genomics revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott Laboratories
Agilent Technologies, Inc
Bio-Rad Laboratories, Inc.
Danaher Corporation
F. Hoffmann-La Roche Ltd
Fluidigm Corporation
General Electric Company
Illumina, Inc.
Merck KGaA
Myriad Genetics, Inc.
Pacific Biosciences of California, Inc.
PerkinElmer
QIAGEN
Siemens Healthineers AG
Thermo Fisher Scientific Inc.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Tumor Genomics, market overview.
Chapter 2: Global Tumor Genomics market size in revenue.
Chapter 3: Detailed analysis of Tumor Genomics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Tumor Genomics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
